Amifostine: the first selective-target and broad-spectrum radioprotector.
about
Toll-like receptor 5 agonist protects mice from dermatitis and oral mucositis caused by local radiation: implications for head-and-neck cancer radiotherapyProspects in the development of natural radioprotective therapeutics with anti-cancer properties from the plants of Uttarakhand region of IndiaAltering the response to radiation: sensitizers and protectorsNew approaches to radiation protectionCancer concepts and principles: primer for the interventional oncologist-part IIThorough study of reactivity of various compound classes toward the Folin-Ciocalteu reagentData-Based Radiation Oncology: Design of Clinical Trials in the Toxicity Biomarkers Era.Pulmonary toxicity in a rabbit model of stereotactic lung radiation therapy: efficacy of a radioprotector.A new chiral pyrrolyl α-nitronyl nitroxide radical attenuates β-amyloid deposition and rescues memory deficits in a mouse model of Alzheimer diseaseCerium oxide nanoparticles in cancerRadiation-Induced Oral MucositisTHE POTENTIATION OF THE RADIOPROTECTIVE EFFICACY OF TWO MEDICAL COUNTERMEASURES, GAMMA-TOCOTRIENOL AND AMIFOSTINE, BY A COMBINATION PROPHYLACTIC MODALITY.Effect of amifostine, a radiation-protecting drug, on oxygen concentration in tissue measured by EPR oximetry and imagingA Combination of Podophyllotoxin and Rutin Alleviates Radiation-Induced Pneumonitis and Fibrosis through Modulation of Lung Inflammation in MiceA Short-Term Biological Indicator for Long-Term Kidney Damage after Radionuclide Therapy in MiceNormal tissue studies in radiation oncology: A systematic review of highly cited articles and citation patterns.Recombinant human MFG-E8 attenuates intestinal injury and mortality in severe whole body irradiation in ratsEvaluation of the efficacy of radiation-modifying compounds using γH2AX as a molecular marker of DNA double-strand breaksTristetraprolin mediates radiation-induced TNF-α production in lung macrophages.Design and Synthesis of a Mitochondria-Targeted Mimic of Glutathione Peroxidase, MitoEbselen-2, as a Radiation Mitigator.Radioprotectors and mitigators of radiation-induced normal tissue injuryWR1065 mitigates AZT-ddI-induced mutagenesis and inhibits viral replication.Medical Countermeasures for Radiation Exposure and Related Injuries: Characterization of Medicines, FDA-Approval Status and Inclusion into the Strategic National Stockpile.In Vivo Delivery of Tinospora cordifolia Root Extract Preventing Radiation-Induced Dystrophies in Mice OvariesA Combination of Podophyllotoxin and Rutin Attenuates Radiation Induced Gastrointestinal Injury by Negatively Regulating NF-κB/p53 Signaling in Lethally Irradiated Mice.A Novel Nitronyl Nitroxide with Salicylic Acid Framework Attenuates Pain Hypersensitivity and Ectopic Neuronal Discharges in Radicular Low Back Pain.Stable isotope gas chromatography-tandem mass spectrometry determination of aminoethylcysteine ketimine decarboxylated dimer in biological samplesQuantification of damage due to low-dose radiation exposure in mice: construction and application of a biodosimetric model using mRNA indicators in circulating white blood cells.Chemical genoprotection: reducing biological damage to as low as reasonably achievable levels.A possible prevention strategy of radiation pneumonitis: combine radiotherapy with aerosol inhalation of hydrogen-rich solution.Prevention of radiation-induced bone pathology through combined pharmacologic cytoprotection and angiogenic stimulation.Haematopoietic, Antioxidant and Membrane Stabilizing Property of Diallyl Disulphide in Irradiated Mice.Sensitization of pancreatic cancer cells to radiation by cerium oxide nanoparticle-induced ROS production.The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: long-term follow-up of Radiation Therapy Oncology Group (RTOG) randomized trial 9801.Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysisEffect of WR-1065 on 6-hydroxydopamine-induced catalepsy and IL-6 level in rats.Radioiodine-induced kidney damage and protective effect of amifostine: An experimental study.Amifostine induces antioxidant enzymatic activities in normal tissues and a transplantable tumor that can affect radiation responseWound healing in radiated skin: pathophysiology and treatment options.Alternate delivery route for amifostine as a radio-/chemo-protecting agent.
P2860
Q24606104-A61D1F7E-F78D-44AC-8AB1-FA2A2E13FD71Q26744792-5DC576E4-E567-46A9-B5FC-BC1EE2303FCFQ26865377-F88BDC96-E476-4A1A-B3A8-AAE26204E981Q27005588-1ECF9C10-D1E1-496B-99DD-8585C94EF1DAQ27010961-6F8BEA87-5EC7-48C3-9F56-E2A3ABB9AF71Q28286331-07574CA6-DB23-442B-984C-0AD7F142FF8AQ30234489-784DE377-B8D1-483B-943B-167DBE14D438Q30458357-4E576CE7-272E-4115-977B-57A410D02F74Q30538829-988F398A-EAB1-4962-9AF1-94076D21DFE5Q33706871-5FE8FC66-D8B5-4577-B64C-4D80782BE622Q33711362-4BD0B3C2-8D32-42D4-890C-EC77F8120FBFQ33728050-585118D1-32AE-4AF9-AABA-7D0C59E5749EQ33751114-BD64F89E-A7FC-4E06-A9D0-58A952EEA476Q33780592-550FE9B3-7271-4D34-B0A4-875FB92C3B46Q33851549-239578B4-561B-49F4-BF10-ADF7D0F0B893Q33967649-6A66764C-B627-407C-A5B1-2DBABFA72DDAQ34441608-6FDD21AE-9656-42F8-80FB-1519699CF1E1Q34567095-329A154A-5DBA-4B38-A441-1E2480188DFCQ34611964-E23EE03C-2D51-42B2-9CD0-1EB2498EC4C2Q34701269-B5DD1506-C826-44EA-8677-56B235EEC415Q34790801-673090B5-8487-46A1-A736-9BD5B3E37340Q35394336-3587D818-2E81-46E8-AAF3-D4864204A6A6Q35566671-0D9F6888-A36B-4ABA-8CEF-1FEB86DC6C0FQ36016000-69666805-447F-4B49-B722-76D2D77204C3Q36236345-B2D10FBD-9631-45EE-96B3-2BE22C23ABE0Q36279182-41C328CA-3EE8-4D08-A7F1-9FB0B20C4CCAQ36291480-85682E74-CC0C-474C-8E81-F98132B8461AQ36451639-F9C9610F-07F9-4BE3-A95A-4E3A7CBC398BQ36461281-95C2460C-5132-4339-B224-4673C94F72FCQ36516380-AEC13792-9931-4BF0-BD71-1ED883E88DEEQ36647029-F86275AF-A9F7-4555-85FE-17CACD75728FQ36708421-CFA8A752-BCFB-49F1-9E89-914C225CD1FBQ36710245-C7CAE80E-51FA-4891-AD3C-47EA810028E3Q36823982-3FECA9F9-1A89-45F6-A180-126112BC3F09Q37014825-C59E17B2-64B2-40DC-9358-06355B22B394Q37043711-1D37D099-A291-4122-8644-CC9C6894A217Q37082662-41B31517-6D53-4C1D-8501-C6C369D9B7E9Q37156624-78B2D4CD-45CB-4D72-8C35-618DF025E99DQ37169643-4E67B53F-90B6-4CA3-804C-C96D94745CEEQ37189789-3DAD7280-E4C7-4358-97BE-B022C7ACAA8E
P2860
Amifostine: the first selective-target and broad-spectrum radioprotector.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Amifostine: the first selective-target and broad-spectrum radioprotector.
@ast
Amifostine: the first selective-target and broad-spectrum radioprotector.
@en
Amifostine: the first selective-target and broad-spectrum radioprotector.
@nl
type
label
Amifostine: the first selective-target and broad-spectrum radioprotector.
@ast
Amifostine: the first selective-target and broad-spectrum radioprotector.
@en
Amifostine: the first selective-target and broad-spectrum radioprotector.
@nl
prefLabel
Amifostine: the first selective-target and broad-spectrum radioprotector.
@ast
Amifostine: the first selective-target and broad-spectrum radioprotector.
@en
Amifostine: the first selective-target and broad-spectrum radioprotector.
@nl
P2093
P1433
P1476
Amifostine: the first selective-target and broad-spectrum radioprotector.
@en
P2093
John R Kouvaris
Lampros J Vlahos
Vassilis E Kouloulias
P304
P356
10.1634/THEONCOLOGIST.12-6-738
P577
2007-06-01T00:00:00Z